Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Iranian Clinical Practice Guideline for Amyotrophic Lateral Sclerosis Publisher



Boostani R1 ; Olfati N1 ; Shamshiri H2, 3 ; Salimi Z4, 5 ; Fatehi F2, 3 ; Hedjazi SA6 ; Fakharian A7, 8, 9 ; Ghasemi M10 ; Okhovat AA2, 3 ; Basiri K10, 11 ; Haghi Ashtiani B12 ; Ansari B10, 11, 13 ; Raissi GR14, 15 ; Khatoonabadi SA16 Show All Authors
Authors
  1. Boostani R1
  2. Olfati N1
  3. Shamshiri H2, 3
  4. Salimi Z4, 5
  5. Fatehi F2, 3
  6. Hedjazi SA6
  7. Fakharian A7, 8, 9
  8. Ghasemi M10
  9. Okhovat AA2, 3
  10. Basiri K10, 11
  11. Haghi Ashtiani B12
  12. Ansari B10, 11, 13
  13. Raissi GR14, 15
  14. Khatoonabadi SA16
  15. Sarraf P17, 18
  16. Movahed S19, 20
  17. Panahi A2, 3
  18. Ziaadini B21, 22
  19. Yazdchi M23, 24
  20. Bakhtiyari J16
  21. Nafissi S2, 3

Source: Frontiers in Neurology Published:2023


Abstract

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegeneration involving motor neurons. The 3–5 years that patients have to live is marked by day-to-day loss of motor and sometimes cognitive abilities. Enormous amounts of healthcare services and resources are necessary to support patients and their caregivers during this relatively short but burdensome journey. Organization and management of these resources need to best meet patients' expectations and health system efficiency mandates. This can only occur in the setting of multidisciplinary ALS clinics which are known as the gold standard of ALS care worldwide. To introduce this standard to the care of Iranian ALS patients, which is an inevitable quality milestone, a national ALS clinical practice guideline is the necessary first step. The National ALS guideline will serve as the knowledge base for the development of local clinical pathways to guide patient journeys in multidisciplinary ALS clinics. To this end, we gathered a team of national neuromuscular experts as well as experts in related specialties necessary for delivering multidisciplinary care to ALS patients to develop the Iranian ALS clinical practice guideline. Clinical questions were prepared in the Patient, Intervention, Comparison, and Outcome (PICO) format to serve as a guide for the literature search. Considering the lack of adequate national/local studies at this time, a consensus-based approach was taken to evaluate the quality of the retrieved evidence and summarize recommendations. Copyright © 2023 Boostani, Olfati, Shamshiri, Salimi, Fatehi, Hedjazi, Fakharian, Ghasemi, Okhovat, Basiri, Haghi Ashtiani, Ansari, Raissi, Khatoonabadi, Sarraf, Movahed, Panahi, Ziaadini, Yazdchi, Bakhtiyari and Nafissi.
Other Related Docs
4. Persian Adaptation of Edinburgh Cognitive and Behavioural Screen (Ecas), Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2021)
17. Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis, Current Stem Cell Research and Therapy (2016)